These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 25899606

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Very Mild Hypothermia (35°C) Postischemia Reduces Infarct Volume and Blood/Brain Barrier Breakdown Following tPA Treatment in the Mouse.
    Cechmanek BK, Tuor UI, Rushforth D, Barber PA.
    Ther Hypothermia Temp Manag; 2015 Dec; 5(4):203-8. PubMed ID: 26075540
    [Abstract] [Full Text] [Related]

  • 5. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
    Roncal C, Martinez de Lizarrondo S, Salicio A, Chevilley A, Rodriguez JA, Rosell A, Couraud PO, Weksler B, Montaner J, Vivien D, Páramo JA, Orbe J.
    Cardiovasc Res; 2017 Aug 01; 113(10):1219-1229. PubMed ID: 28379489
    [Abstract] [Full Text] [Related]

  • 6. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
    Copin JC, Bengualid DJ, Da Silva RF, Kargiotis O, Schaller K, Gasche Y.
    Eur J Neurosci; 2011 Oct 01; 34(7):1085-92. PubMed ID: 21895804
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ.
    Stroke; 2015 May 01; 46(5):1344-1351. PubMed ID: 25804925
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N.
    Eur J Neurosci; 2014 Jun 01; 39(12):2107-18. PubMed ID: 24649933
    [Abstract] [Full Text] [Related]

  • 12. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul 01; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
    Won S, Lee JH, Wali B, Stein DG, Sayeed I.
    J Cereb Blood Flow Metab; 2014 Jan 01; 34(1):72-80. PubMed ID: 24045404
    [Abstract] [Full Text] [Related]

  • 15. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T, Rosenberg GA.
    Stroke; 2003 Aug 01; 34(8):2025-30. PubMed ID: 12855824
    [Abstract] [Full Text] [Related]

  • 16. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
    Culp WC, Brown AT, Lowery JD, Arthur MC, Roberson PK, Skinner RD.
    Mol Neurobiol; 2015 Oct 01; 52(2):979-84. PubMed ID: 26055229
    [Abstract] [Full Text] [Related]

  • 17. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Oct 01; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 18. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P.
    Stroke; 2013 Mar 01; 44(3):699-707. PubMed ID: 23422087
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.